Cutler Group’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Cutler Group’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13	Closed	-$1K	–	6250
2021 Q4	$1K	Sell	13 -7	-35%	-$590	﹤0.01%	5221
2021 Q3	$1K	Sell	20 -180	-90%	-$17.1K	﹤0.01%	5520
2021 Q2	$3K	Buy	200 +140	+233%	+$13.6K	﹤0.01%	4876
2021 Q1	$2K	Sell	60 -180	-75%	-$18.3K	﹤0.01%	5064
2020 Q4	$2K	Buy	240 +120	+100%	+$10.2K	﹤0.01%	4287
2020 Q3	$1K	Sell	120 -90	-43%	-$10.5K	﹤0.01%	4509
2020 Q2	$1K	Buy	+210	New	+$11.6K	﹤0.01%	4217

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cutler Group's VBIV Position: Q2 2023 in Review

Cutler Group sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 40 shares.

Cutler Group first reported a position in VBIV in Q1 2020 and held it in 13 quarters. The position peaked at $23K in Q1 2021. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

Cutler Group reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
Cutler Group sold 40 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023.
Cutler Group first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2020 and held it in 13 quarters.
Cutler Group's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $23K in Q1 2021.
46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.